FDA Clears COVID Booster Shot for Healthy Kids Ages 5 to 11

U.S. regulators on Tuesday authorized a COVID-19 booster shot for healthy 5- to 11-year-olds, hoping an extra vaccine dose will enhance their protection as infections once again creep upward. Everyone 12 and older already was supposed to get one booster dose for the best protection against the newest coronavirus variants—and some people, including those 50 … Read more

‘The Window is Closing’: White House Warns U.S. Faces New COVID-19 Risk Without More Shots

WASHINGTON (AP) — White House COVID-19 coordinator Dr. Ashish Jha issued a dire warning Thursday that the U.S. will be increasingly vulnerable to the coronavirus this fall and winter if Congress doesn’t swiftly approve new funding for more vaccines and treatments. In an Associated Press interview, Jha said Americans’ immune protection from the virus is … Read more

Long-Lasting Birth Control Is Already Hard to Get. Advocates Worry It May Only Get Worse

When Rachel, a 35-year-old from Colorado, learned four years ago that she was pregnant despite taking birth control pills, she wanted to make sure it didn’t happen again. The stakes were high: in addition to not wanting kids, she has a uterine deformity that makes pregnancy risky. She terminated the pregnancy, then began looking for … Read more

State Laws Are Treating Fentanyl Like the New Crack—And Making the Same Mistakes of the 80s and 90s

Since the U.S. drug war was declared in 1971, various drugs have been identified as public enemy number one—from crack cocaine, in the 1980s, to prescription opioids in the early 2000s. Today, the primary villain is fentanyl, a synthetic opioid about 50 times more potent than heroin. In 2021, more than 71,000 people in the … Read more

Here’s What You Need to Know About Paxlovid

Prescriptions for Pfizer’s COVID-19 antiviral medication Paxlovid—the first such pill to be authorized by the U.S. Food and Drug Administration (FDA)—have increased tenfold in the past two months. Between late February and April 22, the number of patients using Paxlovid jumped from 8,000 to 80,000, according to Pfizer CEO Albert Bourla; the drug is now … Read more